Follow the Money: Intercept Pharmaceuticals, Inc.
Intercept Pharmaceuticals recently raised almost $367 million in the completion of a secondary public offering. The company depends upon Contract Research Organi-zations to conduct its clinical trials. Contract Development & Manufacturing Organi-zations should also take note that…
Proprietary Global Sourcing Intelligence in an Instant
Decision-makers at CMOs, CDMOs and Bio/Pharma companies rely on Strategic Advantage, to understand industry trends and company capabilities. Quickly get hard-to-find information and benefit from PharmSource’s trademark quantitative approach to analysis. Learn more
Aenova Expands Injectables Capacity, Consolidates Network
Aenova has made a significant investment to expand its injectables capacity while consolidating the rest of its manufacturing network.
The company announced the completion of a €6 million ($6.6 million) investment at its injectables facility in Wolfratshausen, Germany. The project provided for…